Anthony E. Dragun , MD

Multidisciplinary Clinic

Breast

Clinical Expertise

Breast Cancer
Radiation Oncology

Research Interests

Principal Investigator

  • RTOG 0413/NSABP B-39: A randomized phase III study of conventional whole breast irradiation (WBI) versus partial breast irradiation (PBI) for women with stage 0, I, or II breast cancer
    • Sponsor: RTOG
    • Grant Funding: RTOG
    • Open: July 2009-Present
  • The role of complement in the development of acute radiation dermatitis in patients undergoing whole-breast radiotherapy for early-stage breast cancer: a pilot study
    • Sponsor: Potentia Pharmaceuticals
    • Grant Funding: $25,000 seed grant (pending)
    • Open: Pending IRB
  • A phase III randomized study of massage therapy in the management of breast cancer patients radiation-induced fatigue and insomnia.  (In Preparation)
    • Sponsor: Pending
    • Grant Funding: Pending
    • Open: Pending IRB (Floyd Memorial Hospital, New Albany, IN)

Education

2006-2007
Medical University of South Carolina
Charleston, SC
Chief Resident: Radiation Oncology

2003-2006
Medical University of South Carolina
Charleston, SC
Resident: Radiation Oncology

2002-2003
Temple University, Crozer-Chester Medical Center
Chester, PA
Intern: Transitional Internship

1998-2002
MCP-Hahnemann University School of Medicine
Philadelphia, PA
Doctor of Medicine
Summa Cum Laude

1993-1997
Colgate University
Hamilton, NY
Bachelor of Arts, Molecular Biology
Cum Laude, Honors in Molecular Biology

Professional Memerships

2002-present            American Medical Association

2003-present             American College of Radiology

2003-present             American Society for Therapeutic Radiology and Oncology

2003-present             Southern Medical Association

2005-present            American Brachytherapy Society

2005-present            American College of Radiation Oncology

Employment

Clinical Practice:
November 2008-Present           
University of Louisville
James Graham Brown Cancer Center, Louisville, KY
Assistant Professor of Radiation Oncology

June 2007-October 2008
Roy Richards, Sr. Cancer Center
Tanner Medical Center, Carrollton, GA
Staff Radiation Oncologist

Other Positions:
January 2009-Present           
University of Louisville
Radiation Oncology Chair Search Committee

Board Certification

ABR Board Certified in Radiation Oncology: 10-year certificate (June 1, 2008-June 1, 2018)

Professional Licensure

State of Kentucky: permanent license
State of Indiana: permanent license
State of Georgia: permanent license
State of South Carolina: permanent license
State of North Carolina: permanent license

Honors & Awards

2003-2007
Medical University of South Carolina

American Brachytherapy Society Scholarship Award (2006). Travel
grant and merit award for the 27th annual meeting of ABS, May, 2006.

American College of Radiation Oncology Scholarship Award
(2006). Travel grant and merit award for the 16th annual meeting of ACRO, February, 2006.

South Carolina Medical Association Scholarship Award
(2007). Travel grant and merit award for the 159th annual meeting of SCMA, May, 2007.

1998-2002      
MCP-Hahnemann University School of Medicine

The Dean’s Award for a Universally High Level of Accomplishment, Professional Maturity and Outstanding Potential.  Awarded to the top-performing student in the graduating class.

Alpha Omega Alpha Medical Honor Society, Delta Zeta Chapter.

Publications

Dragun AE, Pan J, Jain D, et al. Locoregional recurrence in patients with triple-negative breast cancer: the impact of radiotherapy.  Manuscript in Preparation.

Watkins JM, Herrin AE, Ruppert B, Harper JL, Garrett-Mayer E, Baker MK, Dragun AE, Cole DJ, Jenrette JM. Prognostic factors for ipsilateral breast and overall disease failure in Mammosite brachytherapy (MBT). Manuscript in Preparation.

Harper JL, Watkins JM, Dragun AE, et al. Six-year experience: long-term disease control outcomes for partial breast irradiation using MammoSite balloon brachytherapy. 2009 IN PRESS. Am J Surg.

Brashears JH, Dragun AE, Jenrette JM. Late chest wall toxicity after MammoSite breast brachytherapy. Brachytherapy. 2009 Jan-Mar;8(1):19-25.

Watkins JM, Harper JL, Dragun AE, Ashenafi MS, Sinha D, Li J, Cole DJ, Jenrette JM. Incidence and prognostic factors for seroma development following Mammosite breast brachytherapy (MBT).  Brachytherapy, 2008 Oct-Dec;7(4):305-9.

Dragun AE, Harper JL, Jenrette JM et al. Patient satisfaction and quality of life after MammoSite breast brachytherapy. Am J Surgery 2008 Oct;196(4):545-8.

Cuttino LW, Keisch M, Jenrette JM, Dragun AE et al. Multi-institutional experience using the MammoSite radiation therapy system in the treatment of early stage breast cancer: 2 year results. In Press
International Journal of Radiation Oncology*Biology*Physics. 2008; 71(1): 107-114. 

Dragun AE, Jenrette JM, Pope TL et al. Mammographic surveillance after MammoSite breast brachytherapy: architectural patterns and additional interventions. Am J of Clin Oncol.  2007; 30(6).

Dragun AE, Jenrette JM, Harper JL et al. Predictors of Cosmetic outcome following MammoSite breast brachytherapy. International Journal of Radiation Oncology*Biology*Physics.  2007; 68(2): 354-58.

Dragun AE. Accelerated Partial-Breast Irradiation: A Viable Choice. RT-Image 2007; 20 (37).

Harper JL, Dragun AE. Patient positioning during breast brachytherapy.  Radiation Therapist. Spring 2007

Zauls JA, Dragun AE, Sharma AK. Intensity modulated radiation therapy for unresectable solid pseudopapillary tumor of the pancreas: a case report. Am J of Clin Oncol 2006; 29(6):639-640.

Bhandari RN, Dragun AE, Aguero EG, et al. External beam radiotherapy for perirectal angiomyxoma results in dramatic clinical response and allows a patient to avoid abdominoperineal resection.  Am J of Clin Oncol 2006; 29(3): 318-319.

Dragun AE, Aguero EG, Harmon JF, et al. Chest wall dose in MammoSite breast brachytherapy: radiobiologic estimations of late complication risk based on dose-volume considerations. Brachytherapy 2005; 4 (4): 259-63.
Vu KN, Dragun AE, Cole DJ et al. Accelerated partial breast irradiation using the MammoSite breast brachytherapy technique: a multidisciplinary approach to breast conservation therapy. Commun Oncol 2005; 2: 477-90.

Dragun AE, Harmon JF, & Aguero EG. Defining the target and protecting normal tissue in inverse-planned intensity-modulated radiation therapy (IMRT) for head and neck, prostate and gynecologic cancers: a comparative review. Commun Oncol 2005; 2:299-306.

Peer-Reviewed Publications

Dragun AE, Pan J, Jain D, et al. Locoregional recurrence in patients with triple-negative breast cancer: the impact of radiotherapy.  Manuscript in Preparation.

Watkins JM, Herrin AE, Ruppert B, Harper JL, Garrett-Mayer E, Baker MK, Dragun AE, Cole DJ, Jenrette JM. Prognostic factors for ipsilateral breast and overall disease failure in Mammosite brachytherapy (MBT). Manuscript in Preparation.

Harper JL, Watkins JM, Dragun AE, et al. Six-year experience: long-term disease control outcomes for partial breast irradiation using MammoSite balloon brachytherapy. 2009 IN PRESS. Am J Surg.

Brashears JH, Dragun AE, Jenrette JM. Late chest wall toxicity after MammoSite breast brachytherapy. Brachytherapy. 2009 Jan-Mar;8(1):19-25.

Watkins JM, Harper JL, Dragun AE, Ashenafi MS, Sinha D, Li J, Cole DJ, Jenrette JM. Incidence and prognostic factors for seroma development following Mammosite breast brachytherapy (MBT).  Brachytherapy, 2008 Oct-Dec;7(4):305-9.

Dragun AE, Harper JL, Jenrette JM et al. Patient satisfaction and quality of life after MammoSite breast brachytherapy. Am J Surgery 2008 Oct;196(4):545-8.

Cuttino LW, Keisch M, Jenrette JM, Dragun AE et al. Multi-institutional experience using the MammoSite radiation therapy system in the treatment of early stage breast cancer: 2 year results. In Press
International Journal of Radiation Oncology*Biology*Physics. 2008; 71(1): 107-114. 

Dragun AE, Jenrette JM, Pope TL et al. Mammographic surveillance after MammoSite breast brachytherapy: architectural patterns and additional interventions. Am J of Clin Oncol.  2007; 30(6).

Dragun AE, Jenrette JM, Harper JL et al. Predictors of Cosmetic outcome following MammoSite breast brachytherapy. International Journal of Radiation Oncology*Biology*Physics.  2007; 68(2): 354-58.

Dragun AE. Accelerated Partial-Breast Irradiation: A Viable Choice. RT-Image 2007; 20 (37).

Harper JL, Dragun AE. Patient positioning during breast brachytherapy.  Radiation Therapist. Spring 2007

Zauls JA, Dragun AE, Sharma AK. Intensity modulated radiation therapy for unresectable solid pseudopapillary tumor of the pancreas: a case report. Am J of Clin Oncol 2006; 29(6):639-640.

Bhandari RN, Dragun AE, Aguero EG, et al. External beam radiotherapy for perirectal angiomyxoma results in dramatic clinical response and allows a patient to avoid abdominoperineal resection.  Am J of Clin Oncol 2006; 29(3): 318-319.

Dragun AE, Aguero EG, Harmon JF, et al. Chest wall dose in MammoSite breast brachytherapy: radiobiologic estimations of late complication risk based on dose-volume considerations. Brachytherapy 2005; 4 (4): 259-63.
Vu KN, Dragun AE, Cole DJ et al. Accelerated partial breast irradiation using the MammoSite breast brachytherapy technique: a multidisciplinary approach to breast conservation therapy. Commun Oncol 2005; 2: 477-90.
Dragun AE, Harmon JF, & Aguero EG. Defining the target and protecting normal tissue in inverse-planned intensity-modulated radiation therapy (IMRT) for head and neck, prostate and gynecologic cancers: a comparative review. Commun Oncol 2005; 2:299-306.

 

 

back to top